Bengt Juliusson
Overview
Explore the profile of Bengt Juliusson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eyjolfsdottir H, Eriksdotter M, Linderoth B, Lind G, Juliusson B, Kusk P, et al.
Alzheimers Res Ther
. 2016 Jul;
8(1):30.
PMID: 27389402
Background: Targeted delivery of nerve growth factor (NGF) has emerged as a potential therapy for Alzheimer's disease (AD) due to its regenerative effects on basal forebrain cholinergic neurons. This hypothesis...
2.
Wahlberg L, Lind G, Almqvist P, Kusk P, Tornoe J, Juliusson B, et al.
J Neurosurg
. 2012 Jun;
117(2):340-7.
PMID: 22655593
Object: The authors describe the first clinical trial with encapsulated cell biodelivery (ECB) implants that deliver nerve growth factor (NGF) to the cholinergic basal forebrain with the intention of halting...
3.
Fjord-Larsen L, Kusk P, Tornoe J, Juliusson B, Torp M, Bjarkam C, et al.
Mol Ther
. 2010 Jul;
18(12):2164-72.
PMID: 20664524
Nerve growth factor (NGF) prevents cholinergic degeneration in Alzheimer's disease (AD) and improves memory in AD animal models. In humans, the safe delivery of therapeutic doses of NGF is challenging....
4.
Villa A, Liste I, Courtois E, Seiz E, Ramos M, Meyer M, et al.
Exp Cell Res
. 2009 Mar;
315(11):1860-74.
PMID: 19327351
Neural stem cells (NSCs) are powerful research tools for the design and discovery of new approaches to cell therapy in neurodegenerative diseases like Parkinson's disease. Several epigenetic and genetic strategies...
5.
Khan Z, Akhtar M, Asklund T, Juliusson B, Almqvist P, Ekstrom T
Exp Cell Res
. 2007 Jun;
313(13):2958-67.
PMID: 17555745
Enzyme prodrug therapy using neural progenitor cells (NPCs) as delivery vehicles has been applied in animal models of gliomas and relies on gap junction communication (GJC) between delivery and target...
6.
Christophersen N, Gronborg M, Petersen T, Fjord-Larsen L, Jorgensen J, Juliusson B, et al.
Exp Neurol
. 2007 Feb;
204(2):791-801.
PMID: 17320866
Affymetrix GeneChip technology and quantitative real-time PCR (Q-PCR) were used to examine changes in gene expression in the adult murine substantia nigra pars compacta (SNc) following lentiviral glial cell line-derived...
7.
Jorgensen J, Juliusson B, Henriksen K, Hansen C, Knudsen S, Petersen T, et al.
Exp Neurol
. 2006 Feb;
198(2):427-37.
PMID: 16473350
In the human embryo, from approximately 6 weeks gestational age (GA), dopaminergic (DA) neurons can be found in the ventral mesencephalon (VM). More specifically, the post-mitotic neurons are located in...